Vincent Ribrag, MD
Institut Gustave Roussy Cancer Campus Grand Paris · Gustave Roussy, Cancer Campus, Grand Paris · Institut Gustave Roussy, France
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Vincent Ribrag, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:24 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT02889523 · Study of Tazemetostat in Newly Diagnosed Diffuse Large B Cell and Follicular Lymphoma Patients Treated by ChemiotherapyThe Lymphoma Academic Research Organisation · active not recruiting · Lymphoma, DLBCL, Follicular Lymphoma · study chair
- N/ANCT02260739 · Sequential Analysis in Patients With an HemopathyGustave Roussy, Cancer Campus, Grand Paris · unknown · Hemopathy · study chair
- Ph1NCT01098188 · LFB-R603 Dose Finding in Patients With Advanced Stage B-Chronic Lymphocytic LeukemiaLaboratoire français de Fractionnement et de Biotechnologies · completed · Chronic Lymphocytic Leukemia · principal investigator
- Ph1NCT00910728 · Study to Assess the Safety of AZD1480 in Patients With Myeloproliferative DiseasesAstraZeneca · completed · Primary Myelofibrosis (PMF), Post-Polycythaemia Vera, Essential Thrombocythaemia Myelofibrosis · principal investigator
- Ph2NCT00884286 · Multicenter Trial to Treat Patients With Relapsed/Refractory Aggressive Non Hodgkin LymphomaPharmaMar · completed · Leukemia, Lymphoma · principal investigator
- Ph3NCT00180882 · LMBA02 Protocol for Patients With a Burkitt LymphomaGustave Roussy, Cancer Campus, Grand Paris · unknown · Burkitt Lymphoma · principal investigator
- Ph2NCT00136591 · A Phase 2 Study of Velcade™ in Subjects With Relapsed or Refractory Follicular B-Cell LymphomaLymphoma Study Association · terminated · Follicular Lymphoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:24 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.